Voyxact (sibprenlimab-szsi) dosage and usage

Voyxact (sibeprenlimab-szsi), a drug used for subcutaneous injection to treat primary immunoglobulin A nephropathy (IgAN), may reduce urinary protein, known as proteinuria, in adult patients who are at risk of worsening of the condition. The recommended dose is 400 mg every 4 weeks. If the patient misses the scheduled dose when taking the medication, he should replenish it as soon as possible and then continue to take the medication as frequently as every 4 weeks.

In terms of administration,VOYXACT can be injected by the patient themselves or by a caregiver. Prior to use, it is important that patients and caregivers are properly trained according to the instructions for use to ensure they understand how to use VOYXACT correctly. The prefilled syringe should be carefully checked before use to ensure that the solution inside is clear and milky white to colorless yellow. If particles, turbidity or discoloration are found, the syringe should be stopped immediately.

Allow prefilled syringe to reach 77°F (25°C) at room temperature for 15 to 30 minutes before injection. When storing, it should be kept in the original carton to avoid the influence of light. Do not use prefilled syringes if left at room temperature for more than 7 days. VOYXACT is limited to subcutaneous injection, and the recommended injection site is the front of the thigh or abdomen. If the injection is administered by a healthcare provider, the back upper arm may also serve as an injection site. It is important to avoid injecting the same site repeatedly or injecting in areas with moles, scars, bruises, etc. to ensure the safety and effectiveness of the injection.

In summary,VOYXACT must be used in strict accordance with the recommended dosage and injection method to ensure the efficacy of the drug and patient safety. At the same time, patients and caregivers should be adequately trained to master self-administration skills and be able to identify potential problems with use.

Reference materials:https://go.drugbank.com/drugs/DB18919